Diabetes mellitus: a hypercoagulable state - PubMed (original) (raw)
Review
Diabetes mellitus: a hypercoagulable state
M E Carr. J Diabetes Complications. 2001 Jan-Feb.
Abstract
Eighty percent of patients with diabetes mellitus die a thrombotic death. Seventy-five percent of these deaths is due to cardiovascular complications, and the remainder is due to cerebrovascular events and peripheral vascular complications. Vascular endothelium, the primary defense against thrombosis, is abnormal in diabetes. Endothelial abnormalities undoubtedly play a role in the enhanced activation of platelets and clotting factors seen in diabetes. Coagulation activation markers, such as prothrombin activation fragment 1+2 and thrombin-anti-thrombin complexes, are elevated in diabetes. The plasma levels of many clotting factors including fibrinogen, factor VII, factor VIII, factor XI, factor XII, kallikrein, and von Willebrand factor are elevated in diabetes. Conversely, the level of the anticoagulant protein C (PC) is decreased. The fibrinolytic system, the primary means of removing clots, is relatively inhibited in diabetes due to abnormal clot structures that are more resistant to degradation and an increase in plasminogen activator inhibitor type 1 (PAI-1). Increased circulating platelet aggregates, increased platelet aggregation in response to platelet agonists, increased platelet contractile force (PCF), and the presence of higher plasma levels of platelet release products, such as beta-thromboglobulin, platelet factor 4, and thromboxane B(2), demonstrate platelet hyperactivity in diabetes. This constellation of findings supports the clinical observation that diabetes is a hypercoagulable state. This article briefly reviews the published evidence for this conclusion and the putative roles played by hyperglycemia and hyperinsulinemia in its development.
Similar articles
- Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.
Sobel BE, Schneider DJ. Sobel BE, et al. Cardiol Clin. 2004 Nov;22(4):511-26. doi: 10.1016/j.ccl.2004.06.009. Cardiol Clin. 2004. PMID: 15501620 Review. - AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. O'Leary JG, et al. Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12. Gastroenterology. 2019. PMID: 30986390 Review. - Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
Erem C, Hacihasanoğlu A, Celik S, Ovali E, Ersöz HO, Ukinç K, Deger O, Telatar M. Erem C, et al. Med Princ Pract. 2005 Jan-Feb;14(1):22-30. doi: 10.1159/000081919. Med Princ Pract. 2005. PMID: 15608477 - Type 2 diabetes: an atherothrombotic syndrome.
Dunn EJ, Grant PJ. Dunn EJ, et al. Curr Mol Med. 2005 May;5(3):323-32. doi: 10.2174/1566524053766059. Curr Mol Med. 2005. PMID: 15892651 Review. - Von Willebrand factor in diabetic angiopathy.
Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M. Kessler L, et al. Diabetes Metab. 1998 Sep;24(4):327-36. Diabetes Metab. 1998. PMID: 9805643 Review.
Cited by
- Metabolic landscape in venous thrombosis: insights into molecular biology and therapeutic implications.
Cao Z, Jiang X, He Y, Zheng X. Cao Z, et al. Ann Med. 2024 Dec;56(1):2401112. doi: 10.1080/07853890.2024.2401112. Epub 2024 Sep 19. Ann Med. 2024. PMID: 39297312 Free PMC article. Review. - Platelet indices as predictors of poor glucoregulation in type 2 diabetes mellitus adults at Bishoftu General Hospital, Ethiopia.
Regassa DA, Berihun GA, Habtu BF, Haile WB, Nagaash RS, Kiya GT. Regassa DA, et al. World J Diabetes. 2024 Sep 15;15(9):1889-1902. doi: 10.4239/wjd.v15.i9.1889. World J Diabetes. 2024. PMID: 39280177 Free PMC article. - Sub-massive Pulmonary Embolism and New-Onset Diabetes Mellitus.
Rama S, Fonarov I, Casadesus D. Rama S, et al. Cureus. 2024 Jul 17;16(7):e64751. doi: 10.7759/cureus.64751. eCollection 2024 Jul. Cureus. 2024. PMID: 39156451 Free PMC article. - Triple Threat: A Case Presentation of Pulmonary Embolism With Diabetic Ketoacidosis and Lower Respiratory Tract Infection.
Shinde VS, Dixit Y. Shinde VS, et al. Cureus. 2024 Jul 11;16(7):e64364. doi: 10.7759/cureus.64364. eCollection 2024 Jul. Cureus. 2024. PMID: 39130871 Free PMC article. - Emerging patterns of hypercoagulability associated with critical COVID-19: A review.
Frazer JS, Tyrynis Everden AJ. Frazer JS, et al. Trends Anaesth Crit Care. 2020 Oct;34:4-13. doi: 10.1016/j.tacc.2020.07.004. Epub 2020 Jul 9. Trends Anaesth Crit Care. 2020. PMID: 38620391 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous